Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was the main pathogen in
the COVID-19 pandemic. This viral infection has been associated with several respiratory …

COVID-19 is currently considered the ninth-deadliest pandemic, spreading through direct or
indirect contact with infected individuals. It has imposed a consistent strain on both the …

Severe Acute Respiratory Syndrome Corona Virus (SARS-CoV-2) is the causative agent of
COVID-19 pandemic, which has resulted in global fatalities since late December 2019 …

Tyrosine kinase inhibitors (TKIs) represent a pivotal class of targeted therapies in oncology,
with multiple generations developed to address diverse molecular targets. Imatinib is the first …

Favipiravir (FAV) a promising therapeutic candidate for addressing COVID-19, has attracted
significant attention in recent times. In an attempt to optimize its delivery and minimize its …

Introduction The gut microbiota (GM) play a significant role in the infectivity and severity of
COVID-19 infection. However, the available literature primarily focuses on adult patients and …

Colon cancer is traditionally treated by an antimetabolite drug 5-fluorouracil (5FU) but has
been linked to several drawbacks and systemic toxicity. To overcome drug associated …

SARS‐CoV‐2 led to deadly and adverse impacts in the recent outbreak in 2019 due to the
lack of effective treatments. The current study aimed to evaluate the potential of antiviral …

Repurposing existing drugs and assessing commercially available inhibitors against
druggable viral sites might be a potent approach for expediting the drug development in the …

HIV has a host cell, T‑cell lymphocytes with CD4+ receptors. HIV drugs have the inhibitory
activity on HIV‑1 protease by producing chemical bonding interactions such as hydrogen …